Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 7781

1.

Pluripotent Stem Cells for Modelling and Cell Therapy of Parkinson's Disease.

Lebedeva OS, Lagarkova MA.

Biochemistry (Mosc). 2018 Sep;83(9):1046-1056. doi: 10.1134/S0006297918090067. Review.

2.

Inhibition of Lithium Sensitive Orai1/ STIM1 Expression and Store Operated Ca2+ Entry in Chorea-Acanthocytosis Neurons by NF-κB Inhibitor Wogonin.

Sukkar B, Hauser S, Pelzl L, Hosseinzadeh Z, Sahu I, Al-Maghout T, Bhuyan AAM, Zacharopoulou N, Stournaras C, Schöls L, Lang F.

Cell Physiol Biochem. 2018;51(1):278-289. doi: 10.1159/000495229. Epub 2018 Nov 19.

3.

Efficient Generation of Non-Integration and Feeder-Free Induced Pluripotent Stem Cells from Human Peripheral Blood Cells by Sendai Virus.

Ye H, Wang Q.

Cell Physiol Biochem. 2018;50(4):1318-1331. doi: 10.1159/000494589. Epub 2018 Oct 24.

4.

Polycaprolactone electrospun fiber scaffold loaded with iPSCs-NSCs and ASCs as a novel tissue engineering scaffold for the treatment of spinal cord injury.

Zhou X, Shi G, Fan B, Cheng X, Zhang X, Wang X, Liu S, Hao Y, Wei Z, Wang L, Feng S.

Int J Nanomedicine. 2018 Oct 10;13:6265-6277. doi: 10.2147/IJN.S175914. eCollection 2018.

5.

Highly efficient transfection of human induced pluripotent stem cells using magnetic nanoparticles.

Yamoah MA, Moshref M, Sharma J, Chen WC, Ledford HA, Lee JH, Chavez KS, Wang W, López JE, Lieu DK, Sirish P, Zhang XD.

Int J Nanomedicine. 2018 Oct 5;13:6073-6078. doi: 10.2147/IJN.S172254. eCollection 2018.

6.

Generation of a Urine-Derived Ips Cell Line from a Patient with a Ventricular Septal Defect and Heart Failure and the Robust Differentiation of These Cells to Cardiomyocytes via Small Molecules.

Cao Y, Xu J, Wen J, Ma X, Liu F, Li Y, Chen W, Sun L, Wu Y, Li S, Li J, Huang G.

Cell Physiol Biochem. 2018;50(2):538-551. doi: 10.1159/000494167. Epub 2018 Oct 11.

7.

Synergistic effect of co-immobilized FGF-2 and vitronectin-derived peptide on feeder-free expansion of induced pluripotent stem cells.

Sohi AN, Naderi-Manesh H, Soleimani M, Yasaghi ER, Manjili HK, Tavaddod S, Nojehdehi S.

Mater Sci Eng C Mater Biol Appl. 2018 Dec 1;93:157-169. doi: 10.1016/j.msec.2018.07.072. Epub 2018 Jul 26.

PMID:
30274048
8.

Defined Xeno-free and Feeder-free Culture Conditions for the Generation of Human iPSC-derived Retinal Cell Models.

Slembrouck-Brec A, Nanteau C, Sahel JA, Goureau O, Reichman S.

J Vis Exp. 2018 Sep 6;(139). doi: 10.3791/57795.

PMID:
30247478
9.

Interleukin-22 promotes phagolysosomal fusion to induce protection against Salmonella enterica Typhimurium in human epithelial cells.

Forbester JL, Lees EA, Goulding D, Forrest S, Yeung A, Speak A, Clare S, Coomber EL, Mukhopadhyay S, Kraiczy J, Schreiber F, Lawley TD, Hancock REW, Uhlig HH, Zilbauer M, Powrie F, Dougan G.

Proc Natl Acad Sci U S A. 2018 Oct 2;115(40):10118-10123. doi: 10.1073/pnas.1811866115. Epub 2018 Sep 14.

10.

A new immunodeficient retinal dystrophic rat model for transplantation studies using human-derived cells.

Thomas BB, Zhu D, Lin TC, Kim YC, Seiler MJ, Martinez-Camarillo JC, Lin B, Shad Y, Hinton DR, Humayun MS.

Graefes Arch Clin Exp Ophthalmol. 2018 Nov;256(11):2113-2125. doi: 10.1007/s00417-018-4134-2. Epub 2018 Sep 13.

PMID:
30215097
11.

Application of CRISPR/Cas9 technologies combined with iPSCs in the study and treatment of retinal degenerative diseases.

Cai B, Sun S, Li Z, Zhang X, Ke Y, Yang J, Li X.

Hum Genet. 2018 Sep;137(9):679-688. doi: 10.1007/s00439-018-1933-9. Epub 2018 Sep 10. Review.

PMID:
30203114
12.

Endogenous Protein Tagging in Human Induced Pluripotent Stem Cells Using CRISPR/Cas9.

Haupt A, Grancharova T, Arakaki J, Fuqua MA, Roberts B, Gunawardane RN.

J Vis Exp. 2018 Aug 25;(138). doi: 10.3791/58130.

13.

Human iPSC-derived trigeminal neurons lack constitutive TLR3-dependent immunity that protects cortical neurons from HSV-1 infection.

Zimmer B, Ewaleifoh O, Harschnitz O, Lee YS, Peneau C, McAlpine JL, Liu B, Tchieu J, Steinbeck JA, Lafaille F, Volpi S, Notarangelo LD, Casanova JL, Zhang SY, Smith GA, Studer L.

Proc Natl Acad Sci U S A. 2018 Sep 11;115(37):E8775-E8782. doi: 10.1073/pnas.1809853115. Epub 2018 Aug 28.

PMID:
30154162
14.

Telomere shortening is a hallmark of genetic cardiomyopathies.

Chang ACY, Chang ACH, Kirillova A, Sasagawa K, Su W, Weber G, Lin J, Termglinchan V, Karakikes I, Seeger T, Dainis AM, Hinson JT, Seidman J, Seidman CE, Day JW, Ashley E, Wu JC, Blau HM.

Proc Natl Acad Sci U S A. 2018 Sep 11;115(37):9276-9281. doi: 10.1073/pnas.1714538115. Epub 2018 Aug 27.

15.

Novel therapeutic strategies for advanced ovarian cancer by using induced pluripotent stem cell-derived myelomonocytic cells producing interferon beta.

Imamura Y, Tashiro H, Tsend-Ayush G, Haruta M, Dashdemberel N, Komohara Y, Tsuboki J, Takaishi K, Ohba T, Nishimura Y, Katabuchi H, Senju S.

Cancer Sci. 2018 Nov;109(11):3403-3410. doi: 10.1111/cas.13775. Epub 2018 Oct 24.

16.

Modeling human somite development and fibrodysplasia ossificans progressiva with induced pluripotent stem cells.

Nakajima T, Shibata M, Nishio M, Nagata S, Alev C, Sakurai H, Toguchida J, Ikeya M.

Development. 2018 Aug 23;145(16). pii: dev165431. doi: 10.1242/dev.165431.

17.

The current status of stem cell therapy in ischemic heart disease.

Michler RE.

J Card Surg. 2018 Sep;33(9):520-531. doi: 10.1111/jocs.13789. Epub 2018 Aug 22. Review.

PMID:
30136308
18.

Application of human induced pluripotent stem cell-derived cardiomyocytes sheets with microelectrode array system to estimate antiarrhythmic properties of multi-ion channel blockers.

Izumi-Nakaseko H, Hagiwara-Nagasawa M, Naito AT, Goto A, Chiba K, Sekino Y, Kanda Y, Sugiyama A.

J Pharmacol Sci. 2018 Aug;137(4):372-378. doi: 10.1016/j.jphs.2018.07.011. Epub 2018 Aug 4.

19.

Stem Cell Therapy in Heart Diseases - Cell Types, Mechanisms and Improvement Strategies.

Müller P, Lemcke H, David R.

Cell Physiol Biochem. 2018;48(6):2607-2655. doi: 10.1159/000492704. Epub 2018 Aug 17. Review.

20.

Tyrosyl-tRNA synthetase stimulates thrombopoietin-independent hematopoiesis accelerating recovery from thrombocytopenia.

Kanaji T, Vo MN, Kanaji S, Zarpellon A, Shapiro R, Morodomi Y, Yuzuriha A, Eto K, Belani R, Do MH, Yang XL, Ruggeri ZM, Schimmel P.

Proc Natl Acad Sci U S A. 2018 Aug 28;115(35):E8228-E8235. doi: 10.1073/pnas.1807000115. Epub 2018 Aug 13.

Supplemental Content

Loading ...
Support Center